Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|August 18, 2024
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective AnalysisAndrew Kent, Kellen B Gil, Michael K Jones, et al.
The Journal of Experimental Medicine|February 25, 2017
A myeloid tumor suppressor role for NOL3Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, et al.
American Journal of Hematology|February 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid LeukemiaMichael K Jones, Jesse Sanchez, Megan Connor, et al.
Nature Medicine|September 8, 2015
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O Vogler, Swathi Narayanagari, et al.
Eclinicalmedicine|October 27, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trialDaniel A Pollyea, Brett M Stevens, Diana Abbott, et al.
Haematologica|April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemiaJonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Cancer Research|December 30, 2010
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinaseLi Zhou, Christine McMahon, Tushar Bhagat, et al.
Haematologica|February 26, 2026
Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapyJustin Watts, Ellen Madarang, Diana Abbott, et al.
The Journal of Biological Chemistry|May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, et al.
Pageof 4